PPBT - Purple Biotech - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PPBT is currently covered by 1 analysts with an average price target of $17. This is a potential upside of $-49.33 (888.37%) from yesterday's end of day stock price of $1.72.

Purple Biotech's activity chart (see below) currently has 16 price targets and 17 ratings on display. The stock rating distribution of PPBT is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 75.64% with an average time for these price targets to be met of 210.6 days.

Highest price target for PPBT is $17, Lowest price target is $17, average price target is $17.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 07-Aug-2026. First documented stock forecast 21-Nov-2017.

Best performing analysts who are covering PPBT - Purple Biotech:

Matthew Barcus Emily Bodnar Raghuram Selvaraju Catherine Novack

Currently out of the existing stock ratings of PPBT, 1 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 17-Oct-2022

$17

$15.28 (888.37%)

$34

1 months 5 days ago
(07-Aug-2026)

8/13 (61.54%)

$15.57 (1088.81%)

248

Buy Since 21-Jul-2023

$60

$55.99 (1396.26%)

$3200

2 years 3 months 9 days ago
(03-Jun-2024)

1/2 (50%)

$-88 (-59.46%)

113

Buy Since 08-Feb-2023

$220

$215.87 (5226.88%)

$220

3 years 3 months 26 days ago
(17-May-2023)

2/2 (100%)

$-157 (-41.64%)

124

Buy Since 21-Nov-2017

$60

$56.02 (1407.54%)

$60

5 years 11 months 15 days ago
(28-Sep-2020)

5/5 (100%)

$-25.2 (-29.58%)

320

Show more analysts

Please expand the browser size to see the chart

What is PPBT (Purple Biotech) average time for price targets to be met?

On average it took 211 days for the stock forecasts to be reached, with an average price target met ratio of 75.64%.

Which analyst most recently updated their price target on PPBT (Purple Biotech)?

Emily Bodnar

Which analyst has the current lower performing score on PPBT (Purple Biotech) with a proven track record?

CATHERINE NOVACK

Which analyst has the most public recommendations on PPBT (Purple Biotech)?

Emily Bodnar works at HC WAINWRIGHT and has 17 price targets and 20 ratings on PPBT

Which analyst is the currently most bullish on PPBT (Purple Biotech)?

Matthew Barcus with the highest potential upside of $215.87

Which analyst is the currently most reserved on PPBT (Purple Biotech)?

Emily Bodnar with the lowest potential downside of $15.28

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?